FRTD Financials

Cancer Care Takes a Leap with New Leadership The shuffle in the leadership ranks within the hallowed halls of NYU Langone's Perlmutter Cancer Center signals yet another step forward in the wild race against cancer. As of November 1, Vivek Subbiah, MD, is grabbing the reins over at the Early-Phase Drug Development and Rare Cancer Programs. This isn’t your average mundane...

There's a fresh breeze blowing through the building industry, and it's got "net zero" written all over it. Green Builder Media is rolling out a pile of new resources aimed at wrangling this beast of a trend. The focus? High-performance, all-electric homes. And they're not just whispering about it—they've got hard data and practical guidance to back up their claims. Net...

Sony's Bold Move into Medical Tech You wouldn't expect a company like Sony to make waves in the medical field, but there they go again, shaking things up with their latest announcement. Lurking past the shiny consumer electronics, they've got the IMX742, a sensor designed for single-use endoscopes. A humble 1 mm square powerhouse, boasting about 0.51 megapixels of digital...

Valaris and Transocean: A Closer Look at the Deal Diving right into it, folks, we've got Kahn Swick & Foti, LLC taking a hard look at the proposed sale of Valaris Limited over to Transocean Ltd. Now, on paper, this might seem like another run-of-the-mill corporate shuffle, but not so fast. There're a few rocky waters here that might make even the hardest boiled of us...

Decoding the Changing Travel Landscape This ain't your grandparents' travel itinerary. The 2026-2027 travel season is already shaping up to be a wild reimagining of what it means to 'get away.' Omio's latest NowNext Travel Report, crafted alongside YouGov, pulls back the curtain on how folks are recalibrating their vacations in light of financial squeezes and climate...

A New Era for New York City Streets The wheels of progress sometimes turn slowly, but when they do, they can make one hell of a statement. New York City's Council passing Romanch's Law is the kind of bold move one might have thought overdue. But here we are, facing a brave new world where horse-drawn carriages—a symbol of old-time charm to some and unnecessary cruelty...

Unicycive's Tumultuous Journey Lately, it's been a rocky road for Unicycive Therapeutics, Inc., with their stock free-falling 39.1% in the span of a heartbeat on June 30, 2026. What sparked this nosedive? The FDA kicked back their revised New Drug Application for a kidney disease treatment yet again, spotlighting old manufacturing issues never nipped in the bud. Talk...

Colorado's Unpredictable Weather: Don't Get Caught Cold The leaves turning color might be the signal of fall, but in Colorado, the weather seems to have a mind of its own—sunny one moment, bone-chilling the next. Denver homeowners, it's time to take a hard look at your outdoor sprinkler systems. Why? Because those freezing nights can sneak up faster than you'd think and...

Building Blocks for Future Health Experts They say money talks, and down in San Antonio, it just shouted loud and clear. Texas A&M University-San Antonio sliced the ribbon on a $55 million Public Health and Education building, a step that isn’t just about bricks and mortar, but life-saving insights and hands-on training that'll ripple across South Texas. This isn’t...

Revving Up the Intralogistics Engine Körber's move to grab a slice of NAiSE isn't just another acquisition. It's like turbocharging an already decent engine, propelling intralogistics into a new gear. For those not in the know, Körber's fame in the realm of supply chain solutions isn't just about size; it's about precision and innovation. And NAiSE? Think of them as the...

BioSyent's Financial Performance Overview BioSyent Inc. has recently announced its financial outcomes for the second quarter (Q2) and the first half (H1) of the year, showing promising growth across all sectors. The company, known for its innovative pharmaceutical products, reported notable increases in sales and profit margins. This positive trend reflects its strong...

MediCapture Introduces aiScope™ for Veterinary Training Revolutionizing Medical AI CHEROKEE, Texas — MediCapture Inc., recognized for its prowess in medical imaging technology, has announced the exciting launch of aiScope™. This innovative software operates Vision AI models in real-time, directly on selected MediCapture devices, providing tremendous opportunities in...

Unpacking the EquipmentShare Fiasco Woah, can't say there aren't fireworks going off at EquipmentShare (NASDAQ:EQPT) these days. Lawsuits piling up like pancakes at a Sunday brunch. And guess what? EquipmentShare's stock took a nosedive, shaking retail investors down to their core. This ain't just any bump in the road—it's messy, sticky, and if you're holding $EQPT,...

Exciting Leadership Change at BioCryst Pharmaceuticals Today, BioCryst Pharmaceuticals, Inc. has announced a significant addition to its leadership team with the appointment of Babar Ghias as Chief Financial Officer (CFO) and head of corporate development. Mr. Ghias will bring to the role a wealth of experience aimed at driving financial strategy and growth within the...

Getting banking infrastructure right in the United States is genuinely hard. Not hard in a "read more documentation" way. Hard in a "you won't know what you missed until it bites you six months in" way. The U.S. financial system is layered, fragmented, and built on decades of overlapping regulation. For any company trying to move fast, whether entering the market fresh or...